- Name
- Bosera Hang Seng SCHK Innovative Drug Select ETF
- Index tracked
- Hang Seng SCHK Innovative DrugSel PR CNY
- Type
- Equity
- Management fee
- 0.5%
- Dividend policy
- Monthly
- NAV
- CNY 0.711 (07/29/2026)
- Issued units
- 722.45M (06/30/2026)
- Listing date
- Jul 23, 2025
- Sponsor
- Bosera Asset Management Co., Limited
- Custodian
- Huatai Securities Co Ltd